Trevi is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions.

Biotechnology

Education

Trevi Therapeutics

Jennifer Good

Paula Buckley

Katie McManus

Angela Hudson Davis, DrPH

Katherine Takaki

Thomas Sciascia

Farrell Simon

David Clark

Lisa Delfini

The executive team at Trevi Therapeutics has a history of experience in the pharmaceutical industry, with a focus on respiratory and cardiovascular drugs. The team has also held positions at various accounting firms, such as Deloitte & Touche and Marcum LLP. In addition, they have also served on the board of the International Festival of Arts & Ideas.

CEO and Executive Team

Board of Directors

Leadership Team

CEO and Executive Team

About

Team members

Other teams at Trevi Therapeutics

Board of Directors

Leadership Team